Needham Reiterates Hold on Zimmer Biomet Holdings
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has reiterated a Hold rating on Zimmer Biomet Holdings (NYSE:ZBH).
August 08, 2024 | 10:09 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Needham analyst Mike Matson has reiterated a Hold rating on Zimmer Biomet Holdings.
The reiteration of a Hold rating suggests that the analyst does not see significant upside or downside potential in the short term. This is likely to result in a neutral impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100